Charles River Laboratories International, Inc. (CRL) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Charles River Laboratories International, Inc. (CRL), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Charles River Laboratories International, Inc., analysts forecast revenue rising from $4.01B in 2025 to $5.07B in 2030; the average estimate for 2030 earnings per share is $18.20; with published estimates ranging from $17.95 to $18.54; 13 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Charles River Laboratories International, Inc. (CRL) forecast — frequently asked questions
What is the analyst price target for Charles River Laboratories International, Inc.?
Analysts covering Charles River Laboratories International, Inc. (CRL) have a consensus price target of $313.67, 5.6% below the current price of $332.16. Published targets range from $219.00 to $388.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Charles River Laboratories International, Inc.'s earnings?
The average analyst estimate for Charles River Laboratories International, Inc. (CRL) earnings per share in 2030 is 18.20, with individual estimates between 17.95 and 18.54.
How much revenue is Charles River Laboratories International, Inc. expected to make?
Analysts forecast Charles River Laboratories International, Inc. (CRL) revenue of $5.07B in 2030, based on 7 published estimates.
How many analysts cover CRL?
13 analysts contribute estimates for Charles River Laboratories International, Inc. (CRL). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Diagnostics & Research stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.